Search Filters
Tags
hyaluronic acid
Tags
osteoarthritis treatment
Tags
Physical Therapy
Clear All
Search
Tags
hyaluronic acid
Tags
osteoarthritis treatment
Tags
Physical Therapy
277 results found in 60ms
ChondroFiller injection versus knee replacement for focal defects
avatar
Miss Sophie Harris
13/8/2026
ChondroFiller injection versus knee replacement for focal defects
ChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.ChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.
ChondroFiller™ durability compared with Arthrosamid
avatar
Miss Sophie Harris
12/8/2026
ChondroFiller™ durability compared with Arthrosamid
ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.
ChondroFiller versus hyaluronic acid for cartilage defects
avatar
Miss Sophie Harris
3/8/2026
ChondroFiller versus hyaluronic acid for cartilage defects
ChondroFiller fills discrete cartilage defects using a cell-recruiting scaffold; hyaluronic acid treats diffuse osteoarthritis through joint lubrication. They address different pathologies, and the choice depends on imaging, not on how much pain a patient experiences.ChondroFiller fills discrete cartilage defects using a cell-recruiting scaffold; hyaluronic acid treats diffuse osteoarthritis through joint lubrication. They address different pathologies, and the choice depends on imaging, not on how much pain a patient experiences.
What the ChondroFiller evidence actually shows
avatar
Miss Sophie Harris
19/7/2026
What the ChondroFiller evidence actually shows
ChondroFiller's reoperation rate of 3–8% substantially outperforms microfracture (41%) and ACI/MACI (37%), reflecting its mechanism: the scaffold supports hyaline-like cartilage repair rather than the fibrocartilage scar tissue that other approaches produce.ChondroFiller's reoperation rate of 3–8% substantially outperforms microfracture (41%) and ACI/MACI (37%), reflecting its mechanism: the scaffold supports hyaline-like cartilage repair rather than the fibrocartilage scar tissue that other approaches produce.
ChondroFiller and Arthrosamid serve different knee conditions
avatar
Miss Sophie Harris
14/7/2026
ChondroFiller and Arthrosamid serve different knee conditions
ChondroFiller recruits progenitor cells to rebuild focal cartilage defects, whilst Arthrosamid provides permanent cushioning for diffuse osteoarthritis by integrating into the joint capsule; the choice between them follows from what MRI reveals about the damage pattern, not from symptom severity.ChondroFiller recruits progenitor cells to rebuild focal cartilage defects, whilst Arthrosamid provides permanent cushioning for diffuse osteoarthritis by integrating into the joint capsule; the choice between them follows from what MRI reveals about the damage pattern, not from symptom severity.
ChondroFiller vs PRP for focal cartilage defects
avatar
Miss Sophie Harris
3/7/2026
ChondroFiller vs PRP for focal cartilage defects
Focal cartilage defects and diffuse cartilage loss are different problems requiring different solutions. ChondroFiller, a collagen scaffold, physically occupies and stabilises focal voids, recruiting repair cells over 12–24 months. PRP releases growth factors to reduce inflammation but cannot fill a structural gap. Imaging reveals which mechanism addresses the patient's underlying…Focal cartilage defects and diffuse cartilage loss are different problems requiring different solutions. ChondroFiller, a collagen scaffold, physically occupies and stabilises focal voids, recruiting repair cells over 12–24 months. PRP releases growth factors to reduce inflammation but cannot fill a structural gap. Imaging reveals which mechanism addresses the patient's underlying problem.
ChondroFiller or Arthrosamid for your knee
avatar
Miss Sophie Harris
2/7/2026
ChondroFiller or Arthrosamid for your knee
ChondroFiller repairs focal cartilage defects via a collagen scaffold, and Arthrosamid provides cushioning by integrating into the synovial lining — because they target different anatomical structures, the MRI scan, not patient preference, determines which injection is appropriate.ChondroFiller repairs focal cartilage defects via a collagen scaffold, and Arthrosamid provides cushioning by integrating into the synovial lining — because they target different anatomical structures, the MRI scan, not patient preference, determines which injection is appropriate.
ChondroFiller duration vs hyaluronic acid and Arthrosamid
avatar
Miss Sophie Harris
23/6/2026
ChondroFiller duration vs hyaluronic acid and Arthrosamid
ChondroFiller's repair tissue outlasts the scaffold itself: the collagen dissolves within two years, but tissue built by the patient's own progenitor cells persists for three to five years.ChondroFiller's repair tissue outlasts the scaffold itself: the collagen dissolves within two years, but tissue built by the patient's own progenitor cells persists for three to five years.
ChondroFiller injection vs PRP for cartilage repair
avatar
Miss Sophie Harris
10/6/2026
ChondroFiller injection vs PRP for cartilage repair
ChondroFiller fills focal cartilage defects with a collagen scaffold; PRP modulates inflammation in diffuse wear. MRI findings, not symptoms, determine which applies.ChondroFiller fills focal cartilage defects with a collagen scaffold; PRP modulates inflammation in diffuse wear. MRI findings, not symptoms, determine which applies.
Choosing injection treatments for knee, hip and ankle
avatar
Miss Sophie Harris
3/6/2026
Choosing injection treatments for knee, hip and ankle
Hyaluronic acid injections can ease knee osteoarthritis pain for months, but the 2019 ACR/AF guideline recommends against routine use for knee disease and strongly against it for hip disease because average benefit is modest. Microfragmented fat and bone marrow concentrate are more experimental biologic options, with limited evidence and narrower…Hyaluronic acid injections can ease knee osteoarthritis pain for months, but the 2019 ACR/AF guideline recommends against routine use for knee disease and strongly against it for hip disease because average benefit is modest. Microfragmented fat and bone marrow concentrate are more experimental biologic options, with limited evidence and narrower uses in knee arthritis and talar cartilage lesions.
Choosing advanced injection options for knee osteoarthritis
avatar
Miss Sophie Harris
1/6/2026
Choosing advanced injection options for knee osteoarthritis
Arthrosamid, a 2.5% polyacrylamide hydrogel given as a single 6 mL knee injection, is designed to stay in the joint and has extension data showing WOMAC pain improvements maintained to five years. MFAT, PRP and BMAC offer biologic alternatives, but their evidence is smaller and less consistent.Arthrosamid, a 2.5% polyacrylamide hydrogel given as a single 6 mL knee injection, is designed to stay in the joint and has extension data showing WOMAC pain improvements maintained to five years. MFAT, PRP and BMAC offer biologic alternatives, but their evidence is smaller and less consistent.
Choosing Arthrosamid knee injections for osteoarthritis
avatar
Miss Sophie Harris
29/5/2026
Choosing Arthrosamid knee injections for osteoarthritis
Arthrosamid is a single ultrasound-guided hydrogel injection for mild-to-moderate knee osteoarthritis, used when exercise, painkillers and other non-surgical care have not eased function-limiting pain. Early studies show meaningful improvement for many patients at 12 months, but evidence remains less robust than for established treatments.Arthrosamid is a single ultrasound-guided hydrogel injection for mild-to-moderate knee osteoarthritis, used when exercise, painkillers and other non-surgical care have not eased function-limiting pain. Early studies show meaningful improvement for many patients at 12 months, but evidence remains less robust than for established treatments.
277 results found in 60ms